INNOVATE BIOPHARMACEUTICALS INC has a total of 16 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are GUANGZHOU LINK HEALTH MEDICAL TECH CO LTD, NEOVACS and PEGBIO CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | United States | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Madan Jay | 12 |
#2 | Blikslager Anthony | 6 |
#3 | Stine Oscar Colin | 3 |
#4 | Jay Madan | 3 |
#5 | Laumas Sandeep | 2 |
#6 | Anthony Blikslager | 2 |
#7 | Prior Christopher | 2 |
#8 | Oscar Colin Stine | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019199642A1 | Compositions and methods for treating or preventing hyperglycemia, insulin resistance, and associated organ damage | |
WO2019183036A1 | Compositions and methods for potentiating immune checkpoint inhibitor therapy | |
WO2019165346A1 | Compounds and methods for treating tight junction permeability | |
WO2019165345A1 | Compositions and methods for treating or preventing intestinal paracellular permeability | |
WO2018148654A1 | Compositions and methods for treating or preventing environmental enteropathy |